Sanofi (SNYNF) Income from Continuing Operations (2009 - 2026)

Sanofi (SNYNF) has 18 years of Income from Continuing Operations data on file, last reported at 15099106649.04 in Q1 2026.

• Quarterly Income from Continuing Operations rose 14.41% year-over-year to 15099106649.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 91609922723.87 (up 31.96% YoY) and the FY2025 annual result came in at 5973871317.43, up 1.75% from the prior year.
• Income from Continuing Operations slipped to 15099106649.04 in Q1 2026 per SNYNF's latest filing, from 15269922825.82 in the prior quarter.
• The five-year high for Income from Continuing Operations was 54860024079.14 in Q4 2023, with the low at 12496419406.78 in Q1 2024.
• Average Income from Continuing Operations over 5 years is 19564253803.73, with a median of 14887170479.22 recorded in 2022.
• Year-over-year, Income from Continuing Operations jumped 1035.29% in 2022 and tumbled 50.12% in 2024.
• Sanofi's Income from Continuing Operations stood at 20044799985.99 in 2022, then soared by 173.69% to 54860024079.14 in 2023, then plunged by 50.12% to 27366728198.17 in 2024, then tumbled by 44.2% to 15269922825.82 in 2025, then fell by 1.12% to 15099106649.04 in 2026.
• Business Quant data shows SNYNF's Income from Continuing Operations at 15099106649.04 in Q1 2026, 15269922825.82 in Q4 2025, and 46934054752.49 in Q3 2025.